← Eichor
Study identifier: NCT07158463 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit of Sohag University Hospital

Condition: Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit  ·  Sponsor: Sohag University

PhaseN/A
Planned participants25
Who can joinAll sexes, 1 Year to 18 Years
Healthy volunteersNo

About this study

Plasmapheresis also known as a therapeutic plasma exchange (TPE) TPE is an extracorporeal blood purification technique designed for the removal of large-molecular-weight substances. Examples of these substances include pathogenic autoantibodies, immune complexes, cryoglobulins, myeloma light chains, endotoxin, and cholesterol-containing lipoproteins Document the indications, procedures, outcomes, and complications associated with TPE in pediatric patients at Sohag University Hospital. To compare our findings with existing national and international data to identify areas for improvement and standardization. To evaluate the safety and efficacy of TPE in our pediatric nephrology unit.

This description comes directly from the study's public registry record.

Talk to the study team

Shohanda Ahmed Mohamed, Master degree  ·  01228288470  ·  shohandaahmed12345@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Faculty of medicine sohag universitySohag, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07158463